REQUEST A DEMO
Total
USD $0.00
Search more companies

UniCorp Biotech Kft (Hungary)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers | Other Miscellaneous Nondurable Goods Merchant Wholesalers | Other Scientific and Technical Consulting Services
Full name: UniCorp Biotech Kft Profile Updated: August 07, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Hungarian Download a sample report

UniCorp Biotech Kft is a company in Hungary, with a head office in Budapest. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. UniCorp Biotech Kft was incorporated on December 27, 2000. UniCorp Biotech Kft currently employs 56 (2026) people. The latest financial highlights indicate a net sales revenue increase of 33.88% in 2025. Its’ total assets recorded a growth of 25.19%. UniCorp Biotech Kft’s net profit margin increased by 5.32% in 2025.

Headquarters
Csorsz utca 45.
Budapest; Budapest; Postal Code: 1124

Contact Details: Purchase the UniCorp Biotech Kft report to view the information.

Website: http://www.unicorp.hu

Basic Information
Total Employees:
Purchase the UniCorp Biotech Kft report to view the information.
Registered Capital:
Purchase the UniCorp Biotech Kft report to view the information.
Financial Auditors:
Purchase the UniCorp Biotech Kft report to view the information.
Incorporation Date:
December 27, 2000
Key Executives
Purchase this report to view the information.
Manager
Purchase this report to view the information.
Manager
Ownership Details
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after UniCorp Biotech Kft report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
33.88%
Total Operating Revenue
35.87%
Operating Profit
40.39%
EBITDA
37.45%
Net Profit/Loss for the Period
148.74%
Total Assets
25.19%
Total Equity
82.49%
Operating Profit Margin
0.68%
Net Profit Margin
5.32%
Return on Equity (ROE)
12.07%
Debt / Equity
-67.01%
Quick Ratio
0.24%
Cash Ratio
0%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?